Itron IncITRI
Price$86.51Intrinsic value$88.212% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.3B-5.6% YoYTTM through 30 Jun 2026
Net Income $274M+14.6% YoYTTM through 30 Jun 2026
Free Cash Flow $385.4MTTM through 30 Jun 2026

Margins

Current
Gross Margin40.3%
EBITDA Margin15.9%
Operating Margin11.5%
Net Margin11.9%

Returns

18.0%ROE
7.3%ROA
11.2%ROIC

Balance Sheet Health

Debt / Equity1.00x
Current Ratio2.66x
Net Debt$897.2M
Cash & Equivalents$745.2M

Quality Metrics

Altman Z-Score2.24
Piotroski F-Score8 / 9
FCF Margin16.7%
Rule of 4020.4
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.4B
Diluted EPS$5.98TTM
'19'20'21'22'23'24'25
FY2025: $6.50

Dividend

No dividend

Capital Allocation

R&D Spend$214.3M
Capex Intensity1.1%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.